<SEC-DOCUMENT>0001213900-15-000387-index.html : 20150116
<SEC-HEADER>0001213900-15-000387.hdr.sgml : 20150116
<ACCEPTANCE-DATETIME>20150116162551
ACCESSION NUMBER:		0001213900-15-000387
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20150106
FILED AS OF DATE:		20150116
DATE AS OF CHANGE:		20150116

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RELMADA THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001553643
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				455401931
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0630

	BUSINESS ADDRESS:	
		STREET 1:		546 FIFTH AVENUE, 14TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036
		BUSINESS PHONE:		212-702-7163

	MAIL ADDRESS:	
		STREET 1:		546 FIFTH AVENUE, 14TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CAMP NINE, INC.
		DATE OF NAME CHANGE:	20120706

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Yazgi Nabil
		CENTRAL INDEX KEY:			0001629962

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-55347
		FILM NUMBER:		15532912

	MAIL ADDRESS:	
		STREET 1:		401 HAMBURG TURNPIKE
		STREET 2:		SUITE 102
		CITY:			WAYNE
		STATE:			NJ
		ZIP:			07470
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>f3010615yazgi_relmada.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: f3010615yazgi_relmada.html

Document 1 - RAW XML: f3010615yazgi_relmada.xml

</DOCUMENT>
</SEC-DOCUMENT>